[ad_1]
A long-term Australian study shows no benefit for the use of cannabis in patients with pain.
14:31, 19 July 2018
[19659010IntheUnitedStatesCanadaandtheNetherlands Chronic pain off cancer is the most common reason to use cannabis as a drug. But large-scale scientific studies are rare. A long-term Australian study published in the British journal The Lancet Public Health has now shown negative results
People who consume cannabis have more pain and less self-management of their pain
] Gabrielle Campbell
"People who consume cannabis experience more pain and less self-management of their pain, and there is no indication that cannabis reduces the intensity of pain or that it has an opioid effect, "writes Gabrielle Campbell National Center for Research on Alcohol and Drugs at the University of New South Wales in Sydney. The study was funded by the National Australian Medical Research Center and the Australian Government.
No replacement of opioids
The study examined cannabis use in patients with painless cancer for more than four years as opioids. Analgesics prescribed by their doctors. As such, doctors should try to use opioids to relieve pain in these patients only if no other means is available.
The very frequent prescription of opiates for patients with chronic pain without tumor disease has increased in the United States since the 1990s ] Opioid Crisis conducted. More than 42,000 people died of opioids in the United States in 2016 – more than ever before.
In more than 40% of these deaths, health authorities reported having a prescription opioid. Many addicts in the United States have slipped into opioid addiction via prescription painkillers such as oxycodone. Of course, it would be desirable to have therapeutic agents that would reduce the dosage of opioid therapy otherwise necessary
No positive effects
This was not the case with cannabis in the Australian study. Cannabis use was common, with 295 participants (24%) using cannabis as an badgesic at the end of the four-year follow-up period, with 364 subjects (33%) indicating badgesic use at the beginning of the study , against 732 after four years. (60%)
(…) We have found no evidence of a temporal relationship between the use of cannabis and the severity of pain symptoms, pain-related disorders, a reduction in the prescribed opioid dose or an interruption of opioid badgesics
Cannabis in Medicine
The National Council of Health of the National Council recently asked Minister Beate Hartinger-Klein (FPÖ) to submit a report by the end of 2018 on the therapeutic use of cannabis in medicine Create. In the spring, German health insurance technicians published an expert report written with their support on the subject. "Miracles are obviously not to be expected from cannabis in different indications." In pain medicine and paralysis, the quality of scientific evidence of effectiveness is "at most moderate (…) There is no efficacy for cannabis in depression indications , psychosis, dementia, glaucoma and intestinal diseases, "the experts wrote.
Source link
